Stay updated on Azacitidine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine + Pembrolizumab in AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This change is an internal version update and does not modify the visible content or user-facing features.
    Difference
    0.1%
    Check dated 2026-05-18T13:53:26.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Updated the page’s software/revision version indicator from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-27T07:32:30.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T02:48:46.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-22T09:08:00.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Site revision label updated from v3.4.2 to v3.4.3 in the page header/footer.
    Difference
    0.1%
    Check dated 2026-03-07T20:41:18.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied, replacing the previous v3.4.1. No substantive study information or user-facing content was changed.
    Difference
    0.1%
    Check dated 2026-02-14T05:05:24.000Z thumbnail image

Stay in the know with updates to Azacitidine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.